Showing results 1 to 6 of 6
Title | Author(s) | Issue Date | Views | |
---|---|---|---|---|
Impact of epidermal growth factor receptor inhibitor in non-small cell lung cancer on progression-free an overall survival: a meta-analysis Journal:Journal of the National Cancer Institute | 2013 | 45 | ||
2013 | 64 | |||
Phase II study of two eribulin regimens in combination with erlotinib in patients (PTS) with previously treated advanced non-small cell lung cancer (NSCLC) Proceeding/Conference:Annals of Oncology | 2012 | 74 | ||
2014 | 44 | |||
A randomized placebo-controlled phase III study of intercalated erlotinib with gemcitabine/platinum in first-line advanced non-small cell lung cancer (NSCLC): FASTACT-II Proceeding/Conference:Journal of Clinical Oncology | 2012 | 93 | ||
2016 | 74 |